XML 12 R23.htm IDEA: XBRL DOCUMENT v3.19.3
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Accounting change
    Balances at December 31, 2018     Effect of Adoption of New Lease Standard     Balances at January 1, 2019  
Assets                  
  Prepaid Expenses   $ 301,797     $ (35,865 )   $ 265,932  
  Operating Lease Right of Use Asset   $ -     $ 714,421     $ 714,421  
Liabilities                        
  Deferred Rent   $ 13,215     $ (13,215 )   $ -  
  Current Portion of Long-Term Operating Lease   $ -     $ -     $ -  
  Deferred Rent and Tenant Improvement Allowances   $ 401,734     $ (401,734 )   $ -  
  Long-Term Operating Lease, Net of Current Portion   $ -     $ 1,093,505     $ 1,093,505  
Shareholders’ Equity                        
  Accumulated Deficit   $ (41,201,511 )   $ -     $ (41,201,511 )
Net loss per share
   

For the Three Months Ended September 30,

(Unaudited)

  
    2019     2018  
             
Net loss   $ (236,813 )   $ (373,158 )
Adjustments for convertible debt - as converted                
Interest on convertible debt     50,000       53,000  
Amortization of debt discount on convertible debt     -       7,851  
Net loss attributable to common shareholders   $ (186,813 )   $ (312,307 )
Weighted average number of shares of common stock outstanding:                
Basic and diluted     124,709,440       124,290,418  
Net loss attributable to common shareholders per share:                
Basic and diluted   $ (0.00 )   $ (0.00 )

  

   

For the Nine Months Ended September 30,

(Unaudited)

  
    2019     2018  
             
Net loss   $ (1,756,049 )   $ (1,921,977 )
Adjustments for convertible debt - as converted                
Interest on convertible debt     150,000       168,878  
Amortization of debt discount on convertible debt     17,534       23,792  
Net loss attributable to common shareholders   $ (1,588,515 )   $ (1,729,307 )
Weighted average number of shares of common stock outstanding:                
Basic and diluted     124,686,572       123,333,468  
Net loss attributable to common shareholders per share:                
Basic and diluted   $ (0.01 )   $ (0.01 )
Disaggregation of revenue

Product and Service Revenue

 

   

For the three months ended September 30,

(Unaudited)

  
    2019     2018  
SteraMist Product   $ 928,000     $ 1,613,000  
Service and Training     672,000       335,000  
 Total   $ 1,600,000     $ 1,948,000  

 

   

For the nine months ended September 30,

(Unaudited)

  
    2019     2018  
SteraMist Product   $ 3,461,000     $ 3,723,000  
Service and Training     1,031,000       784,000  
 Total   $ 4,492,000     $ 4,507,000  

 

Revenue by Geographic Region

 

   

For the three months ended September 30,

 (Unaudited)

  
    2019     2018  
United States   $ 1,288,000     $ 1,754,000  
International     312,000       194,000  
 Total   $ 1,600,000     $ 1,948,000  

 

   

For the nine months ended September 30,

 (Unaudited)

  
    2019     2018  
United States   $ 3,852,000     $ 3,545,000  
International     640,000       962,000  
 Total   $ 4,492,000     $ 4,507,000